| MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer R Cui, W Meng, HL Sun, T Kim, Z Ye, M Fassan, YJ Jeon, B Li, C Vicentini, ... Proceedings of the National Academy of Sciences 112 (31), E4288-E4297, 2015 | 166 | 2015 |
| miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer G Liang, W Meng, X Huang, W Zhu, C Yin, C Wang, M Fassan, Y Yu, ... Proceedings of the National Academy of Sciences 117 (8), 4347-4357, 2020 | 146 | 2020 |
| MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma W Meng, Z Ye, R Cui, J Perry, V Dedousi-Huebner, A Huebner, Y Wang, ... Clinical cancer research 19 (19), 5423-5433, 2013 | 126 | 2013 |
| Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues W Meng, JP McElroy, S Volinia, J Palatini, S Warner, LW Ayers, ... PloS one 8 (5), e64393, 2013 | 89 | 2013 |
| MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 R Cui, T Kim, M Fassan, W Meng, HL Sun, YJ Jeon, C Vicentini, E Tili, ... Oncotarget 6 (26), 21802, 2015 | 81 | 2015 |
| Distribution of tumor-infiltrating immune cells in glioblastoma E Orrego, CA Castaneda, M Castillo, LA Bernabe, S Casavilca, ... CNS oncology 7 (4), CNS21, 2018 | 69 | 2018 |
| The role of miRNAs in angiogenesis, invasion and metabolism and their therapeutic implications in gliomas S Beyer, J Fleming, W Meng, R Singh, SJ Haque, A Chakravarti Cancers 9 (7), 85, 2017 | 68 | 2017 |
| miR-130a deregulates PTEN and stimulates tumor growth H Wei, R Cui, J Bahr, N Zanesi, Z Luo, W Meng, G Liang, CM Croce Cancer research 77 (22), 6168-6178, 2017 | 60 | 2017 |
| In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines T Lautenschlaeger, J Perry, D Peereboom, B Li, A Ibrahim, A Huebner, ... Radiation oncology 8, 1-10, 2013 | 46 | 2013 |
| Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer W Meng, A Huebner, A Shabsigh, A Chakravarti, T Lautenschlaeger Molecular biology international 2012 (1), 701814, 2012 | 34 | 2012 |
| Overcoming radiation resistance in gliomas by targeting metabolism and DNA repair pathways W Meng, JD Palmer, M Siedow, SJ Haque, A Chakravarti International journal of molecular sciences 23 (4), 2246, 2022 | 21 | 2022 |
| MicroRNA biomarkers for patients with muscle-invasive bladder cancer undergoing selective bladder-sparing trimodality treatment W Meng, J Efstathiou, R Singh, J McElroy, S Volinia, R Cui, A Ibrahim, ... International Journal of Radiation Oncology* Biology* Physics 104 (1), 197-206, 2019 | 21 | 2019 |
| A novel miR-146a-POU3F2/SMARCA5 pathway regulates stemness and therapeutic response in glioblastoma T Cui, EH Bell, J McElroy, K Liu, E Sebastian, B Johnson, PM Gulati, ... Molecular Cancer Research 19 (1), 48-60, 2021 | 15 | 2021 |
| 酸度对胡敏酸与镉和锌离子络合反应的影响 刘保峰， 王强， 孟威， 魏世强 西南大学学报 (自然科学版) 27 (4), 2005 | 10 | 2005 |
| Comparison of gonadal toxicity of single-fraction ultra-high dose rate and conventional radiation in mice MC Cuitiño, JL Fleming, S Jain, A Cetnar, AS Ayan, J Woollard, ... Advances in Radiation Oncology 8 (4), 101201, 2023 | 9 | 2023 |
| The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer C Castañeda, M Castillo, L Bernabe, N Suarez, M Fassan, J Sanchez, ... ecancermedicalscience 16, 1362, 2022 | 5 | 2022 |
| Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas M Bredel, L Espinosa, H Kim, DM Scholtens, JP McElroy, R Rajbhandari, ... Cell Reports Medicine 4 (6), 2023 | 3 | 2023 |
| Lung adenocarcinoma microRNA-31 expression levels to predict lymph node metastasis and patient survival. T Lautenschlaeger, W Meng, Z Ye, R Cui, J Perry, A Huebner, ... Journal of Clinical Oncology 31 (15_suppl), 7573-7573, 2013 | 3 | 2013 |
| 5-hydroxymethylcytosine alterations at H3K9me3 marked genomic regions serve as potential biomarker for renal cell carcinoma patients W Meng, T Lautenschlaeger, D Frankhouser, Z Ye, A Huebner, V Jin, ... Cancer Research 75 (15_Supplement), 2963-2963, 2015 | 1 | 2015 |
| A 6-gene signature for outcome prediction of grade II/III glioma. T Lautenschlaeger, A Huebner, O Oehlke, TA Juratli, B Li, W Meng, ... Journal of Clinical Oncology 32 (15_suppl), 2002-2002, 2014 | 1 | 2014 |
Carlo CroceProfessor, Ohio State UniversityEmail yang diverifikasi di osumc.edu